Pharma News
23 views | +0 today
Follow
Your new post is loading...
Your new post is loading...
Scooped by Erica Friedman
Scoop.it!

Merck Serono appoints Meeta Gulyani as head of Strategy and Global Franchises - The Pharma Letter

Merck Serono appoints Meeta Gulyani as head of Strategy and Global Franchises - The Pharma Letter | Pharma News | Scoop.it
Merck Serono appoints Meeta Gulyani as head of Strategy and Global Franchises The Pharma Letter “I am very pleased to have Meeta on board as we are moving into a new phase of Merck Serono's transformation, focused on growth, and seek to maximize...
more...
No comment yet.
Scooped by Erica Friedman
Scoop.it!

Sun Pharma: All the right ingredients - Business Standard

Sun Pharma: All the right ingredients
Business Standard
Sun Pharma has consistently outperformed benchmark indices and its peers in the last one year.
more...
No comment yet.
Scooped by Erica Friedman
Scoop.it!

Intercept Pharma Drug Scores Pivotal Study Win Against Rare Liver Disease - TheStreet.com

Intercept Pharma Drug Scores Pivotal Study Win Against Rare Liver Disease - TheStreet.com | Pharma News | Scoop.it
Guardian Liberty Voice Intercept Pharma Drug Scores Pivotal Study Win Against Rare Liver Disease TheStreet.com NEW YORK (TheStreet) -- Significantly more patients with a rare liver disease responded to treatment with an experimental drug from...
more...
No comment yet.
Rescooped by Erica Friedman from Social Media and Healthcare
Scoop.it!

A social pill for pharma

A social pill for pharma | Pharma News | Scoop.it

Pharmaceutical companies are slow to board the social media bus, but the rest of the healthcare industry isn’t waiting around. Online health information is readily available, and consumers have no reservations about tapping the Internet to find it.

A Pew Internet survey found that 72 percent searched for healthcare information online in 2012, while 52 percent of smartphone owners have used their device to look up health or medical information. More specifically, one in five U.S. consumers consults social media in making their healthcare decisions.

Likewise, a growing number of healthcare professionals are engaging on social channels, using Facebook, Twitter, LinkedIn, YouTube and blogs to explore job opportunities, network with peers, or find new ways to connect with patients. There’s no arguing that social media is an influential part of the healthcare conversation.

As medicine becomes more participatory, many pharma companies lack confidence in how to engage in social media. Furthermore, some experts question whether industry is even suited for the promotional aspects of Facebook or Twitter or other social channels at all.

Social media: a tough pill to swallow?

So why the hesitation on the part of this industry? A new white paper, “A Social Pill for Pharma”— by Reena Milton and Logan Lawler—explores the unique challenges and opportunities.

Not surprising, the Federal Drug Administration considerations are front and center. While the FDA provides guidelines on social media use by the pharmaceutical industry, it’s still a gray area. According to Milton and Lawler, current FDA regulations and guidelines — especially on the reporting of adverse events and industry standards for pharmaceutical marketing — do not address the realities of social engagements online or provide consistent enforcement of existing rules online.

But that shouldn’t stop pharma from engaging in social media. The opportunities are many, including hearing customers, understanding the competitive landscape and building a brand. The authors write:  “… though social media formats and platforms are likely to evolve over time, online engagement is here to stay. You need to be accessible to your consumers and empower you to improve brand awareness, business results and loyalty.”

By making content easier to share, companies will engage caregivers and their patients online through innovative approaches. This will ultimately build a stronger presence on various social channels, allowing them to listen to conversations and gain valuable insights.

Good medicine

Successful social media engagement is about having the right vision, the right plan, and the necessary diligence. The white paper discusses the ways a social media plan can to the following:

Monitor relevant conversationsDetermine a conversation’s sentimentProvide business or market intelligence repotsIdentify key influencers and channels to broadcast products and servicesBoost customer support and satisfaction

It’s time to board the bus! Healthcare is the No. 3 search topic online, as people research symptoms, diseases, procedures, doctors, hospitals, test results — and, of course, drug and treatment options. With the right approach, pharma companies can join the conversation without compromising federal compliance

 


Via Plus91
more...
No comment yet.
Rescooped by Erica Friedman from India Biotech & Pharma
Scoop.it!

Current scenario and future challenges in pharma segment

Current scenario and future challenges in pharma segment | Pharma News | Scoop.it
Current scenario and future challenges in pharma segment

Via Amar Bhat
more...
Amar Bhat's curator insight, January 24, 2014 9:20 AM

Some good thoughts by the commentator.  

Scooped by Erica Friedman
Scoop.it!

IMS researchers urge pharma to get social - Medical Marketing and ...

IMS researchers urge pharma to get social - Medical Marketing and ... | Pharma News | Scoop.it
IMS Health says 50% of the top-50 pharmas are not on social media. Executive Director Murray Aitken tells MM&M it is to pharma's detriment.
more...
No comment yet.
Scooped by Erica Friedman
Scoop.it!

Should pharma really be aiming to lead social media patient engagement? - mobihealthnews

Should pharma really be aiming to lead social media patient engagement? - mobihealthnews | Pharma News | Scoop.it
mobihealthnews
Should pharma really be aiming to lead social media patient engagement?
more...
No comment yet.
Scooped by Erica Friedman
Scoop.it!

Social Media & Healthcare | | SoLoMo Health: eH...

Social Media & Healthcare | | SoLoMo Health: eH... | Pharma News | Scoop.it
Social Media & Healthcare | on SoLoMo Health: eHealth, mHealth, Health & Social Media, Digital Health, Telehealth, Quantified Self, Wearable Tech curated by Celine Sportisse (Interesting slideshare presentation on Social Media & Healthcare (by...
more...
No comment yet.
Scooped by Erica Friedman
Scoop.it!

Discussion of Patient Social Media Tracking Service | BrightTALK

Discussion of Patient Social Media Tracking Service | BrightTALK | Pharma News | Scoop.it
Join us for a live webinar exploring how we use social media tracking to understand what drugs generate the most buzz, why patients switch from one drug to another, and what patients think about pre-market and marketed therapies.
more...
No comment yet.
Scooped by Erica Friedman
Scoop.it!

Best Price Tindamax 500mg Purchase Us, Where To Purchase Tindamax, Generic Name Tind

Amebiasis Drug Abuse Stomach Stds #amebiasis Medication Best Anti Novartis http://t.co/pBhUS60SYw
more...
No comment yet.
Scooped by Erica Friedman
Scoop.it!

Gates Foundation Health Chief on Coaxing Pharma to Do Good - Xconomy

Gates Foundation Health Chief on Coaxing Pharma to Do Good - Xconomy | Pharma News | Scoop.it
Gates Foundation Health Chief on Coaxing Pharma to Do Good
Xconomy
Bill Gates can summon the CEOs of every major global pharmaceutical company, and get them thinking and talking about things that won't help them make more money.
more...
No comment yet.
Scooped by Erica Friedman
Scoop.it!

Pfizer's rheumatoid arthritis drug OK'd in Japan

Drugmaker Pfizer Inc. said Monday that its new rheumatoid arthritis drug, Xeljanz, has been approved for use in Japan. The Japanese Ministry of Health, Labor and Welfare approved the twice-a-day pill for use in patients ...
more...
No comment yet.
Scooped by Erica Friedman
Scoop.it!

Italy prosecutors open probe against Roche, Novartis executives | Ezspk Health &Fitness news

Italy prosecutors open probe against Roche, Novartis executives http://t.co/S3256s2LgO
more...
No comment yet.
Scooped by Erica Friedman
Scoop.it!

It's bitter medicine by the spoonful for pharma - Deccan Herald

It's bitter medicine by the spoonful for pharma - Deccan Herald | Pharma News | Scoop.it
DigitalJournal.com It's bitter medicine by the spoonful for pharma Deccan Herald The US Food and Drug Administration (FDA) has banned imports from Indian generic drugmaker Sun Pharmaceutical Industries Ltd's plant at Karkhadi in Gujarat, in the...
more...
No comment yet.
Scooped by Erica Friedman
Scoop.it!

Pharma's social media priorities for 2014 - PML...

Pharma's social media priorities for 2014 - PML... | Pharma News | Scoop.it
Pharma's social media priorities for 2014 - PMLiVE on 2- HEALTHCARE SOCIAL MEDIA by PHARMAGEEK curated by Lionel Reichardt / le Pharmageek (Pharma's social media priorities for 2014 - PMLiVE via @CelineSportisse http://t.co/vytOtHMKXF)...
more...
No comment yet.
Rescooped by Erica Friedman from Pharma Digital
Scoop.it!

Can biopharma leverage social media health #pharma

Can biopharma leverage social media health #pharma | Pharma News | Scoop.it

Over the last couple of days I’ve shared some information and data on how patients use social media for health.   Today I would like to share some examples of possible social media interactions with patients.

 

First, it’s important to understand that at its heart social media is a conversation between groups of people.  It is therefore essential to listen first and not use social media to broadcast. Consumers find that highly annoying.  You want to be part of the conversation in a meaningful way.

 

According to the 2011Rodale DTC Study consumers say social media is all about medical conditions and treatments.

 

Read more: http://worldofdtcmarketing.com/can-biopharma-leverage-social-media-health/social-media-and-healthcare/


Via Parag Vora
more...
No comment yet.
Scooped by Erica Friedman
Scoop.it!

J&J, MD Anderson Collaborate on Cancer Immunotherapy - Drug Discovery & Development

J&J, MD Anderson Collaborate on Cancer Immunotherapy - Drug Discovery & Development | Pharma News | Scoop.it
Drug Discovery & Development J&J, MD Anderson Collaborate on Cancer Immunotherapy Drug Discovery & Development The University of Texas MD Anderson Cancer Center will collaborate with Johnson & Johnson Innovation and its affiliate Janssen Biotech...
more...
No comment yet.
Scooped by Erica Friedman
Scoop.it!

Obamacare: Questions for Pharma in 2014

Given that the majority of these products are likely to be high cost, specialty drugs, dedicated to small, niche markets, pharma execs should anticipate that the chances of these drugs becoming first line Obamacare prescription ...
more...
No comment yet.
Scooped by Erica Friedman
Scoop.it!

Lot of pharma stocks still undervalued; to give good returns, going ahead ... - Economic Times

Lot of pharma stocks still undervalued; to give good returns, going ahead ... - Economic Times | Pharma News | Scoop.it
Economic Times
Lot of pharma stocks still undervalued; to give good returns, going ahead ...
Economic Times
Devang Mehta: We had a buy on Torrent Pharma. We have just booked profits, a few days back.
more...
No comment yet.
Scooped by Erica Friedman
Scoop.it!

Autoimmune Diseases: Current Treatments, Unmet Needs, and Patient Recruitment

Autoimmune Diseases: Current Treatments, Unmet Needs, and Patient Recruitment | Pharma News | Scoop.it
Did You Know: There are over 100 #Autoimmune diseases. Learn about current treatments & unmet needs: http://t.co/mI22Au62xa #pharma
more...
No comment yet.
Scooped by Erica Friedman
Scoop.it!

J&J Needs to Earn Investor Loyalty - Wall Street Journal

J&J Needs to Earn Investor Loyalty - Wall Street Journal | Pharma News | Scoop.it
J&J Needs to Earn Investor Loyalty
Wall Street Journal
Not just a storied company, J&J JJSF -2.23% J&J Snack Foods Corp. U.S.: Nasdaq $85.53 -1.95 -2.23% Jan. 17, 2014 4:00 pm Volume (Delayed 15m) : 40,666 AFTER HOURS $85.51 -0.02 -0.02% Jan.
more...
No comment yet.
Scooped by Erica Friedman
Scoop.it!

Pfizer completes spinoff of animal-health unit Zoetis; shares rise - MarketWatch (blog)

Pfizer completes spinoff of animal-health unit Zoetis; shares rise - MarketWatch (blog) | Pharma News | Scoop.it
Pfizer completes spinoff of animal-health unit Zoetis; shares rise
MarketWatch (blog)
Pfizer shareholders are eligible to exchange more than 400 million shares of Pfizer stock for Zoetis shares.
more...
No comment yet.
Scooped by Erica Friedman
Scoop.it!

Novartis looks to data management vendors to slash costs

Novartis looks to data management vendors to slash costs | Pharma News | Scoop.it
Speaking at an investor day late last week, Novartis chief financial officer Harry Kirsch outlined how the company plans to generate "substantial savings" by working with external data management vendors.
more...
No comment yet.